about
Circulating miR-499 as a potential biomarker for acute myocardial infarctionMicroRNAs in the Stressed Heart: Sorting the Signal from the NoiseNon-coding RNAs: the "dark matter" of cardiovascular pathophysiology.HypoxamiR regulation and function in ischemic cardiovascular diseases.MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest?MicroRNA control of high-density lipoprotein metabolism and functionGenome-wide identification of microRNA expression quantitative trait loci.MiRNA and TF co-regulatory network analysis for the pathology and recurrence of myocardial infarctionBiomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing.Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction.Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.Metabolism Regulates Cellular Functions of Bone Marrow-Derived Cells used for Cardiac Therapy.Attenuation of cardiac dysfunction and remodeling of myocardial infarction by microRNA-130a are mediated by suppression of PTEN and activation of PI3K dependent signaling.A cardiac myocyte-restricted Lin28/let-7 regulatory axis promotes hypoxia-mediated apoptosis by inducing the AKT signaling suppressor PIK3IP1.Systems Biology and Noninvasive Imaging of Atherosclerosis.Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarctionCirculating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome.SnoN as a novel negative regulator of TGF-β/Smad signaling: a target for tailoring organ fibrosis.Exosome and its roles in cardiovascular diseases.The emerging roles of long noncoding RNAs in common cardiovascular diseases.Stress response factors as hub-regulators of microRNA biogenesis: implication to the diseased heart.Exosomal miRNAs in Heart Disease.Low Levels of MicroRNA-21 Are a Marker of Reduced Arterial Stiffness in Well-Controlled Hypertension.My heart will go on-beneficial effects of anti-MiR-30 after myocardial infarction.Cardiovascular consequences of metabolic syndrome.Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases.Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia-Reperfusion.NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress.Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension.Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena.Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients.Cardioprotective Effect of MicroRNA-21 in Murine Myocardial Infarction.Elevated levels of granzyme B correlated with miR-874-3p downregulation in patients with acute myocardial infarction.
P2860
Q26750940-68520DFA-7FB5-42E3-BA6B-E1016F28D12EQ26995334-1936151D-3293-4AC3-AB1D-241FC1E23C1CQ27693295-C334A61C-8E1A-4963-A84E-51A37D2F2C08Q34082010-78E7EE92-BEA8-4F1D-990F-21837361002CQ35071551-FAF4F411-32F5-4578-A42F-211BDA9F5155Q35200081-76F77522-4543-4DC8-A3AE-84AA319A4315Q35206403-383D23AF-88A4-4D0A-B7FA-E706370E4D66Q35386890-FCC9B9A0-A060-40FA-B5C7-976FEA09A439Q35679243-4F8A31D5-E4FD-4BA6-B2BB-A6CE2F5711B4Q35705430-458A4466-EFB1-494B-9D91-19FB92260D5FQ35935772-C8042E15-6653-4285-9404-F7EF332AED82Q36008423-ADD42857-B0CF-4CFC-A35F-8F9623AFBDB7Q36399871-A49ABB3B-2E73-462C-8F6D-7A69D930385CQ36519330-DD4DCD80-6657-49A3-BE34-4B0191B313E7Q36884545-EC8BBE9B-3C14-494C-815F-BC2B7F025CE4Q37516362-0650F536-A2E0-47BB-B7E6-6DDC52A49021Q38125100-DC35CE88-735E-4553-B49F-9545DA4CB0A5Q38266174-85F31321-41B9-44C1-8E17-A335886C0F6DQ38304096-24AA76F6-E7A2-4949-A1AE-C74A14D307D1Q38374530-A2BD1F22-9384-43C6-88B9-30E134D4F1EDQ38667356-43B4FAA4-6CC3-4E4C-B8C1-6933AA4AF3A1Q38667736-0AE76CF7-81BE-40EB-8DE8-6D4B1A59C91EQ38828855-539CCFEF-606D-4805-AD83-B2307D733E10Q38869296-EB903928-CF52-40BA-8C93-022AF403F950Q39106973-C558891F-2328-4D34-BD5C-D7F2C8DCB2A0Q40038797-C9B81BD6-266D-44EB-8E98-CD304C085C76Q41102519-60A4FEAB-1927-4D6B-943B-463B5B366370Q41166567-CC493552-1799-42B4-AD3D-9C3988FE59C1Q44551016-B92B1832-0786-4449-9AA7-D2587BB1CE40Q50082577-DFDEFE96-5CB1-4E35-8FCA-F3CA17EED789Q52880307-15BF6527-291D-4243-8A49-5FE2D3AEE8DDQ52956195-FA29873F-7618-4F30-9FEF-06B1FB93084EQ54007969-7BC5EB68-3B11-4121-B37F-8D0157AD2C3D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNAs in myocardial infarction.
@en
type
label
MicroRNAs in myocardial infarction.
@en
prefLabel
MicroRNAs in myocardial infarction.
@en
P1476
MicroRNAs in myocardial infarction
@en
P2093
Jan Fiedler
P304
P356
10.1161/ATVBAHA.112.300137
P407
P50
P577
2013-02-01T00:00:00Z